ATORVASTATIN CALCIUM
NDC 60760-883, ATORVASTATIN CALCIUM, tablet, film coated, from St. Mary's Medical Park Pharmacy.
- Product NDC
- 60760-883
- Status
- Listed
- Labeler
- St. Mary's Medical Park Pharmacy
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214344
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60760-883 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATORVASTATIN CALCIUM TRIHYDRATE20 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60760-883-90 | 60760088390 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-883-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2f76cd3b-fbfa-a193-e063-6294a90a1b32
Use it
Look up 60760-883 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60760-883 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60760-883. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.